It has been shown that FGF21 stimulates lipolysis by decreasing fat stores leading to reducing hepatic steatosis and lipotoxicity (Xu et al., 2009; Tanaka et al., 2015; Bao et al., 2018). This evidence concerns the gene FGF21 and Hepatic steatosis.